Clinical Trials in New York State

Showing 3121-3140 of 8,190 trials

ELUCIDATE FFRct Study

NCT06018194

The goal of this study is to evaluate the diagnostic accuracy of a novel plaque-based coronary CT angiography (CCTA) fractional flow reserve (FFRct) software device for the estimation of invasive fractional flow reserve (FFR). Researchers will compare the Elucid plaque-based FFRct analysis to invasively measured FFR in patients who have previously undergone CCTA and invasively assessed FFR.

Coronary Artery Disease

Elucid Bioimaging Inc.350 participantsStarted Sep 2023

Beverly Hills, California, United States • Atlanta, Georgia, United States • Fort Wayne, Indiana, United States +6 more locations

TERMINATEDPhase 297 miles

Merotocin in Mothers With Inadequate Milk Production and Infants Delivered Prematurely

NCT02545127

Induction and support of lactation in women with preterm delivery and inadequate milk production.

Preterm DeliveryInadequate Milk Production

Ferring Pharmaceuticals4 participantsStarted May 2021

New Haven, Connecticut, United States • South Bend, Indiana, United States • Baltimore, Maryland, United States +7 more locations

ELUCIDATE FFRct Study

Merotocin in Mothers With Inadequate Milk Production and Infants Delivered Prematurely

Find Trials by Condition in New York State

A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical Dystonia

Phase 3 Study of SNF472 for Calciphylaxis

A Study of AL101 Monotherapy in Patients With Notch Activated Triple Negative Breast Cancer

Study in Pediatric Subjects With Peanut Allergy to Evaluate Efficacy and Safety of Dupilumab as Adjunct to AR101 (Peanut Oral Immunotherapy)

REDUCE LAP-HFREF TRIAL

Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA)

Adjunctive Vortioxetine in Schizophrenia

PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Development of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic Cancer

Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes

A Long-Term Safety Trial of LUM-201 in Children With Idiopathic Growth Hormone Deficiency Who Have Previously Completed a LUM-201 Clinical Trial (OraGrowtH211)

A Study Of Safety, Tolerability And Effectiveness Of Recifercept In Children With Achondroplasia

DS-6157a in Participants With Advanced Gastrointestinal Stromal Tumor (GIST)

A Study of H3B-8800 (RVT-2001) in Participants With Lower Risk Myelodysplastic Syndromes

Practice of Acceptance, Awareness, and Compassion in Caregiving (PAACC)

Lung EpiCheck Biomarkers Development Study

Double-Blinded, Placebo-Controlled Phase 1b Study for Safety, PK, Efficacy, PD of RO7049665 in Participants With Ulcerative Colitis (UC)

Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB054707 in Participants With Normal and Impaired Renal Function and Participants on Hemodialysis